Add BrightSurf on Google Email

The Lancet


The Lancet: Experts call for global drug policy reform as evidence shows 'war on drugs' has harmed public health and human rights

A new report by The Lancet and Johns Hopkins University calls for decriminalizing non-violent minor drug offenses, strengthening health and social services for drug users, and implementing evidence-based approaches to drug policy. The report finds that the 'war on drugs' has harmed public health, human rights, and development.

SourceThe Lancet·JournalThe Lancet·DateMar 24, 2016

The Lancet: Low cost, 25 min TB-test could help reduce tuberculosis death rate among patients with HIV in sub-Saharan Africa

A new study published in The Lancet suggests that a low-cost, urine test to diagnose tuberculosis among patients with HIV could save thousands of lives per year in sub-Saharan Africa. The test, which provides results in 25 minutes and costs $2.66, showed an absolute reduction of 4% in TB death rate among patients with HIV.

SourceThe Lancet·JournalThe Lancet·DateMar 9, 2016

Vitamin D supplements in pregnancy do not improve bone health

A randomized controlled trial found that vitamin D supplements during pregnancy have no significant effect on the bone density of babies. However, further analysis suggests that supplementation may counteract the seasonal drop in vitamin D levels caused by lack of sunlight, potentially improving bone health in winter-born babies.

SourceThe Lancet·JournalThe Lancet Diabetes & Endocrinology·DateMar 1, 2016

The Lancet Diabetes & Endocrinology: Reducing sugar content in sugar-sweetened drinks by 40 percent over 5 years could prevent 1.5 million cases of overweight and obesity in the UK and 300,000 cases of diabetes

Reducing sugar content in sugar-sweetened drinks by 40% over 5 years could prevent 1.5 million cases of overweight and obesity in the UK and 300,000 cases of diabetes. This reduction would lead to a significant decrease in energy intake and body weight, resulting in a substantial decrease in these health issues.

SourceThe Lancet·JournalThe Lancet Diabetes & Endocrinology·DateJan 6, 2016

The Lancet Oncology: Price of cancer drugs varies by up to 388% between European countries, Australia, and New Zealand

A study published in The Lancet Oncology reveals that cancer drug prices vary significantly between European countries, with some nations paying up to 388% more than others for the same medication. The UK and Mediterranean countries have the lowest average unit manufacturer prices for a group of 31 originator cancer drugs, while German...

SourceThe Lancet·JournalThe Lancet Oncology·DateDec 3, 2015

The Lancet: Breastfeeding babies protected against HIV infection from their HIV-positive mothers with 12 months of liquid antiretroviral drug treatment

A study found that providing babies with up to 12 months of liquid formula HIV drugs while breastfeeding with their HIV-positive mothers is highly effective in protecting them from infection. The study showed that rates of HIV infection fell to 0.2% when the drug was taken, and that adherence remained a key factor for success.

SourceThe Lancet·JournalThe Lancet·DateNov 18, 2015

The Lancet Infectious Diseases: New gene that makes common bacteria resistant to last-line antibiotic found in animals and patients in China

Researchers found a new gene, mcr-1, that enables bacteria to resist polymyxins, the last line of defence against infections. The gene is widespread in E coli and K pneumoniae strains from pigs and patients in south China, suggesting its potential to spread rapidly into human pathogens.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·DateNov 18, 2015

The Lancet: UN report shows that despite substantial progress, the world fell short of the maternal mortality target in the Millennium Development Goals

Despite a 44% reduction in maternal mortality between 1990 and 2015, the world failed to meet the 75% target set by the Millennium Development Goals. Global progress varied significantly across regions, with some countries achieving impressive declines while others struggled with high mortality rates.

SourceThe Lancet·JournalThe Lancet·DateNov 12, 2015

The Lancet: Progress against cancer in low-income and middle-income countries possible with package of targeted priority interventions

A package of targeted priority interventions can significantly decrease the cancer burden in low-income countries by 2030 and even greater declines by 2050. The essential package includes access to opioid-based pain medications, tobacco control measures, and HPV vaccination, which are feasible, cost-effective, and affordable.

SourceThe Lancet·JournalThe Lancet·DateNov 11, 2015

The Lancet: Smoking set to kill 1 in 3 young men in China

A recent study published in The Lancet reveals that two-thirds of young Chinese men start smoking before age 20, with half eventually dying from tobacco-related causes. The study also shows a significant increase in cigarette smoking among young men, leading to a doubling of male deaths attributed to smoking.

SourceThe Lancet·JournalThe Lancet·DateOct 8, 2015